Table 3 Correlations between neonatal abstinence syndrome and measures of adult opioid use stratified by density of buprenorphine-waivered physicians and outpatient treatment program client case load
From: A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome
Correlation (r; 95% CI) | p-value | |
|---|---|---|
Above median number of buprenorphine waivered physicians per 100,000 population (n = 20)1 | ||
Proportion of individuals with illicit drug dependence or abuse | −0.04 (− 0.48–0.41) | 0.86 |
Rate of opioid prescribing | 0.48 (0.03–0.75) | 0.03 |
Below median number of buprenorphine waivered physicians per 100,000 population (n = 18)1 | ||
Proportion of individuals with illicit drug dependence or abuse | 0.73 (0.38–0.88) | < 0.001 |
Rate of opioid prescribing | 0.39 (−0.10–0.72) | 0.12 |
Above median number of clients in outpatient treatment program per 100,000 population (n = 20)1 | ||
Proportion of individuals with illicit drug dependence or abuse | 0.33 (−0.14–0.67) | 0.16 |
Rate of opioid prescribing | 0.27 (−0.21–0.63) | 0.26 |
Below median number of clients in outpatient treatment program per 100,000 population (n = 18)1 | ||
Proportion of individuals with illicit drug dependence or abuse | 0.59 (0.15–0.82) | 0.01 |
Rate of opioid prescribing | 0.38 (−0.11–0.72) | 0.12 |